Evaluation of supercritical fluid chromatography for testing of PEG adducts in pharmaceuticals

Journal of Pharmaceutical and Biomedical Analysis

Volumn 88, Issue , 2014, Pages 256-261

  Schou Pedersen, Anne Marie V ^a   Østergaard, Jesper ^a   Johansson, Mats ^b   Dubant, Stephane ^c   Frederiksen, Rune B ^d   Hansen, Steen Honoré ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Waters Sverige AB   (Sweden)

^c Waters France ^*  (France)

^d Waters Danmark   (Denmark)

Author keywords

Cetirizine; Drug excipient interaction; Indomethacin; Polyethylene glycol; SFC

Indexed keywords

CARBON DIOXIDE; CETIRIZINE; INDOMETACIN; MACROGOL 3000; MACROGOL 400; MACROGOL 6000; METHANOL; OLIGOMER;

ARTICLE; LIGHT SCATTERING; MASS SPECTROMETRY; MOLECULAR WEIGHT; POLYMERIZATION; PRIORITY JOURNAL; SUPERCRITICAL FLUID CHROMATOGRAPHY;

CETIRIZINE; DRUG-EXCIPIENT INTERACTION; INDOMETHACIN; POLYETHYLENE GLYCOL; SFC;

CARBON DIOXIDE; CETIRIZINE; CHEMISTRY TECHNIQUES, ANALYTICAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, SUPERCRITICAL FLUID; INDOMETHACIN; LIGHT; MASS SPECTROMETRY; METHANOL; POLYETHYLENE GLYCOLS; POLYMERS; SCATTERING, RADIATION; TIME FACTORS;

EID: 84884715338     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.08.039     Document Type: Article

References (33)

1. Akers M.J. Excipient-drug interactions in parenteral formulations. J. Pharm. Sci. 2002, 91:2283-2300.
2. Bruni G., Amici L., Berbenni V., Marini A., Orlandi A. Drug-excipient compatibility studies. J. Therm. Anal. Calorim. 2002, 68:561-573.
3. Crowley P., Martini L. Drug-excipient interactions. Pharm. Tech. Europe 2001, 13:26-34.
4. Qiu F. Identification of drug-excipient interaction products using a stress testing assisted approach. Am. Pharm. Rev. 2006, 9:142-145.
5. Wu Y., Levons J., Narang A., Raghavan K., Rao V. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. AAPS PharmSciTech 2011, 12:1248-1263.
6. Repka M.A., Majumdar S., Battu S.K., Srirangam R., Upadhye S.B. Applications of hot-melt extrusion for drug delivery. Expert Opin. Drug Deliv. 2008, 5:1357-1376.
7. Baillon P., Won C. PEG-modified biopharmaceuticals. Expert Opin. Drug Deliv. 2009, 6:1-16.
8. Greenwald R. PEG drugs: an overview. J. Control Release 2001, 74:159-171.
9. Veronese F.M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 2001, 22:405-417.
10. Greenwald R. Poly(ethylene glycol) anticancer drug delivery systems. P. R. Health Sci. J. 2002, 21:113-121.
11. Jain A., Jain S. PEGylation: an approach for drug delivery. A review. Crit. Rev. Ther. Drug Carrier Syst. 2008, 25:403-447.
12. Kang J.S., DeLuca P.P., Lee K.C. Emerging PEGylated drugs. Expert Opin. Emerg. Drugs 2009, 14:363-380.
13. Glastrup J. Degradation of polyethylene glycol. A study of the reaction mechanism in a model molecule: tetraethylene glycol. Polym. Degrad. Stab. 1996, 52:217-222.
14. Han S., Kim C., Kwon D. Thermal/oxidative degradation and stabilization of polyethylene glycol. Polymer 1997, 38:317-323.
15. Yu H., Cornett C., Larsen J., Hansen S. Reaction between drug substances and pharmaceutical excipients: formation of esters between cetirizine and polyols. J. Pharm. Biomed. Anal. 2010, 53:745-750.
16. Holzbauer H.-R., Just U. Characterisation of oligomer ethylene oxide adducts by SFC. Tenside Surf. Det. 1994, 31:79-82. (in German).
17. Takahashi K., Kinugasa S., Senda M., Kimizuka K., Fukushima K., Matsumoto T., Shibata Y., Christensen J. Quantitative comparison of a corona-charged aerosol detector and an evaporative light-scattering detector for the analysis of a synthetic polymer by supercritical fluid chromatography. J. Chromatogr. A 2008, 1193:151-155.
18. Takahashi K., Kishine K., Matsuyama S., Saito T., Kato H., Kinugasa S. Certification and uncertainty evaluation of the certified reference materials of poly(ethylene glycol) for molecular mass fractions by using supercritical fluid chromatography. Anal. Bioanal. Chem. 2008, 319:2079-2087.
19. Takahashi K., Matsuyama S., Saito T., Kato H., Kinugasa S., Yarita T., Maeda T., Kitazawa H., Bounoshita M. Calibration of an evaporative light-scattering detector as a mass detector for supercritical fluid chromatography by using uniform poly(ethylene glycol) oligomers. J. Chromatogr. A 2008, 1193:146-150.
20. Rissler K. High-performance liquid chromatography and detection of polyethers and their mono(carboxy)alkyl and -arylalkyl substituted derivatives. J. Chromatogr. A 1996, 742:1-54.
21. Lesellier E., Valarche A., West C., Dreux M. Effects of selected parameters on the response of the evaporative light scattering detector in supercritical fluid chromatography. J. Chromatogr. A 2012, 1250:220-226.
22. Rissler K. Improved separation of polyethylene glycols widely differering in molecular weight range by reversed-phase high performance liquid chromatography and evaporative light scattering detection. Chromatographia 1999, 49:615-620.
23. Escott R.E.A., Mortimer N. Analysis of polyethylene glycol and derivatives by high-performance liquid chromatography using elevated temperatures and low-wavelenght ultraviolet detection, and supercritical fluid chromatography. J. Chromatogr. 1991, 553:423-432.
24. Brinz D., Holzgrabe U. Analysis of the molecular size distribution of polyethylene glycols by CE-UV versus HPLC with evaporative light scattering detection. Electrophoresis 2008, 29:3605-3611.
25. 1-receptor antagonist. J. Med. Chem. 1998, 41:853-863.
26. Ishihama Y., Nakamura M., Miwa T., Kajima T., Asakawa N. A rapid method for pKa determination of drugs using pressure-assisted capillary electrophoresis with photodiode array detection in drug discovery. J. Pharm. Sci. 2002, 91:933-942.
27. Taft R.W. Separation of polar, steric and resonance effects in reactivity. Steric effects in Organic Chemistry 1956, 556-677. John Wiley & Sons, Inc., New York. M.S. Newman (Ed.).
28. Kahns A.H., Jensen P.B., Mørk N., Bundgaard H. Kinetics of hydrolysis of indomethacin and indomethacin ester prodrugs in aqueos solution. Acta Pharm. Nord. 1989, I:327-336.
29. Kochling J., Miao H., Young C., Looker A., Shannon M., Montgomery E. Understanding the degradation pathway of a poorly water-soluble drug formulated in PEG-400. J. Pharm. Biomed. Anal. 2007, 43:1638-1646.
30. Bindra D.S., Williams T.D., Stella V.J. Degradation of O6-benzylguanine in aqueous polyethylene glycol 400 (PEG 400) solutions: concerns with formaldehyde in PEG 400. Pharm. Res. 1994, 11:1060-1064.
31. Ginsburg E.J., Stephens D.A., West P.R., Buko A.M., Robinson D.H., Li L.C., Bommireddi A.R. Identification of a yellow impurity in aged samples of aqueous butamben suspension: evidence for the oxidative degradation of poly(ethylene glycol). J. Pharm. Sci. 2000, 89:766-770.
32. Johnson D.M., Taylor W.F. Degradation of fenprostalene in polyethylene glycol 400 solution. J. Pharm. Sci. 1984, 73:1414-1417.
33. Watermann K.C., Arikpo W.B., Fergione M.B., Graul T.W., Johnson B.A., MacDonald B.C., Roy M.C., Timpano R.J. N-methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet. J. Pharm. Sci. 2008, 97:1499-1507.